ArticleProceedings of the National Academy of Sciences of the United States of America2020

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

Olga A Patutina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.